Your browser doesn't support javascript.
loading
Three-dimensional (3D) cell culture: a valuable step in advancing treatments for human hepatocellular carcinoma.
Khafaga, Asmaa F; Mousa, Shaker A; Aleya, Lotfi; Abdel-Daim, Mohamed M.
Afiliación
  • Khafaga AF; Department of Pathology, Faculty of Veterinary Medicine, Alexandria University, Edfina, 22758, Egypt. asmaa.khafaga@alexu.edu.eg.
  • Mousa SA; Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, 12144, USA.
  • Aleya L; Chrono-Environnement Laboratory, UMR CNRS 6249, Bourgogne Franche-Comté University, 25030, Besançon Cedex, France.
  • Abdel-Daim MM; Pharmacology Department, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, 41522, Egypt.
Cancer Cell Int ; 22(1): 243, 2022 Jul 30.
Article en En | MEDLINE | ID: mdl-35908054
ABSTRACT
Hepatocellular carcinoma (HCC) is the fifth most common malignant cancer and the third most frequent cause of tumour-related mortality worldwide. Currently, several surgical and medical therapeutic strategies are available for HCCs; however, the interaction between neoplastic cells and non-neoplastic stromal cells within the tumour microenvironment (TME) results in strong therapeutic resistance of HCCs to conventional treatment. Therefore, the development of novel treatments is urgently needed to improve the survival of patients with HCC. The first step in developing efficient chemotherapeutic drugs is the establishment of an appropriate system for studying complex tumour culture and microenvironment interactions. Three-dimensional (3D) culture model might be a crucial bridge between in vivo and in vitro due to its ability to mimic the naturally complicated in vivo TME compared to conventional two-dimensional (2D) cultures. In this review, we shed light on various established 3D culture models of HCC and their role in the investigation of tumour-TME interactions and HCC-related therapeutic resistance.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cancer Cell Int Año: 2022 Tipo del documento: Article País de afiliación: Egipto

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cancer Cell Int Año: 2022 Tipo del documento: Article País de afiliación: Egipto